Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
PSIL
PSIL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PSIL News
Quantum Biopharma Reports Positive Phase 1 Safety For Multiple Sclerosis Drug
Aug 05 2025
Benzinga
Ex-Gov't Foe Joins Trump, RFK Jr.'s HHS To Lead Psychedelics Policy: What It Means For Investors
May 24 2025
Benzinga
5 ETFs That Beat Market Turmoil With Gains Last Week
Feb 10 2025
Benzinga
Why Is Penny Stock Clearmind Gaining Today?
Dec 24 2024
Benzinga
The Zacks Analyst Blog Highlights AdvisorShares Psychedelics ETF, Simplify Volt Robocar Disruption and Tech ETF, First Trust SkyBridge Crypto Industry & Digital Economy ETF, U.S. Global Jets ETF and First Trust NASDAQ ABA Community Bank Index Fund
Nov 18 2024
NASDAQ.COM
Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment
Jun 05 2024
Benzinga
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
Apr 17 2024
Benzinga
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
Mar 04 2024
Benzinga
Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More
Feb 15 2024
Benzinga
Show More News